⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer
globenewswire.com
AZN
GILD
MRK
PFE
BMY
JNJ
TEVA
United Kingdom NOR Flash Market (2026-2031) - ADAS and EV Platform Adoption Drives Growth
globenewswire.com
IFNNY
MU
WBD
MX
CHKP
ADI
NXPI
STX
AMAT
ASML
KLAC
TER
ADSK
CDNS
SNPS
MRVL
NVDA
AMD
INTC
QCOM
TXN
MCHP
ON
STM
AEHR
AMBA
ALGN
ADBE
ACGL
AEP
AMGN
AMZN
AAPL
AVGO
BIIB
BKNG
BKR
CDW
CEG
CHTR
CMCSA
COST
CRWD
CSCO
CTAS
DDOG
DELL
DLTR
DOX
DXCM
EA
EBAY
EXC
FAST
FIS
FTNT
FTV
GILD
GOOG
GOOGL
HON
IBM
IDXX
ILMN
INTU
ISRG
JD
KDP
KHC
LRCX
LULU
MAR
MDT
MELI
META
MNST
MRNA
MSFT
NFLX
ORLY
PANW
PAYX
PCAR
PEP
PFE
PLTR
PM
POOL
PPC
PSA
REGN
ROST
SBUX
SIRI
SWKS
SYK
TCOM
TEAM
TGT
TMO
TMUS
TSLA
ULTA
VRSK
VRTX
WDAY
WDC
XEL
XOM
ZBRA
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Toll-Like Receptor 8 Agonist Pipeline Gains Momentum as Immuno-Oncology Advances and Clinical Innovation Unlock New Growth Opportunities in 2026
globenewswire.com
GILD
GSK
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
Forge’s Fierce Pharma Week Delivered a Powerhouse Event with Over 3,500 Pharmaceutical and Biotech Decision-Makers and Innovators, Representing a 21% Increase in Attendees Over 2025
globenewswire.com
ABBV
ACAD
AZN
BIIB
BMY
LLY
GILD
PFE
REGN
TEVA
Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
accessnewswire.com
NNVC
SIGA
CHKP
GILD
Microfluidic Control Device Market Poised for Growth as Automation, Precision Medicine, and Lab-on-a-Chip Innovation Drive New Opportunities Through the Forecast Period
globenewswire.com
BIO
ILMN
PHG
TMO
QGEN
NVDA
AMD
MSFT
GOOGL
AMZN
INTC
MU
AMAT
LRCX
KLAC
ASML
REGN
BIIB
GILD
MRNA
PFE
JNJ
EXAS
TSLA
NIO
RIVN
PLUG
FCEL
XOM
CVX
NOC
BA
LMT
GD
RTX
IBM
QCOM
NXPI
ON
ADI
TXN
MCHP
SNPS
CDNS
WDC
ADBE
CRM
GOOG
CRSP